Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Non Operating Income (2016 - 2025)

Veracyte's Non Operating Income history spans 14 years, with the latest figure at $3.4 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 569.81% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $10.4 million, up 8.56%, while the annual FY2025 figure was $10.4 million, 8.56% up from the prior year.
  • Non Operating Income for Q4 2025 was $3.4 million at Veracyte, up from -$4.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.5 million in Q2 2025 and bottomed at -$4.1 million in Q3 2025.
  • The 5-year median for Non Operating Income is $1.6 million (2021), against an average of $1.7 million.
  • The largest YoY upside for Non Operating Income was 3528.57% in 2021 against a maximum downside of 1985.71% in 2021.
  • A 5-year view of Non Operating Income shows it stood at $1.0 million in 2021, then surged by 94.78% to $2.0 million in 2022, then surged by 154.42% to $5.0 million in 2023, then crashed by 114.54% to -$732000.0 in 2024, then skyrocketed by 569.81% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Non Operating Income are $3.4 million (Q4 2025), -$4.1 million (Q3 2025), and $6.5 million (Q2 2025).